pt
| # | Empresa | Ticker | Bolsa | Setor | País | Valor de Mercado | 1S | Variação em 1 ano |
|---|---|---|---|---|---|---|---|---|
| 1 |  Eli Lilly and CompanyLLYNYSE | LLY | NYSE | Empresas Farmacêuticas | United States | $1.12T | +6.6% | +56.6% |
| 2 |  Johnson & Johnson (J&J)JNJNYSE | JNJ | NYSE | Biofarmacêutica | United States | $615.9B | -2.3% | +32.3% |
| 3 |  AbbVie Inc.ABBVNYSE | ABBV | NYSE | Empresas Farmacêuticas | United States | $504.4B | +3.2% | +24.3% |
| 4 |  F. Hoffmann-La Roche AGROGSIX | ROG | SIX | Consumíveis Médicos e Reagentes de Diagnóstico | Switzerland | $371.7B | -9.5% | — |
| 5 |  Merck & Co., Inc.MRKNYSE | MRK | NYSE | Indústria de Produtos Biológicos e Vacinas | United States | $360.1B | +0.2% | +72.1% |
| 6 |  Novartis AGNOVNSIX | NOVN | SIX | Terapia Génica e Celular | Switzerland | $286.3B | +4.7% | +14.6% |
| 7 |  Novo Nordisk A/SNVONYSE | NVO | NYSE | Indústria de Produtos Biológicos e Vacinas | Denmark | $170.0B | — | -24.5% |
| 8 |  Pfizer Inc.PFENYSE | PFE | NYSE | Indústria de Produtos Biológicos e Vacinas | United States | $168.6B | +4.6% | — |
| 9 | BMY | NYSE | Terapia Génica e Celular | United States | $122.0B | +1.1% | +37.0% | |
| 10 |  Sanofi S.A.SNYNYSE | SNY | NYSE | Indústria de Produtos Biológicos e Vacinas | France | $97.3B | +0.6% | -19.8% |
- 01
Eli Lilly and Company
LLYNYSEUnited States
$1.12T
+6.6% 1W·+56.6% 1Y
- 02
Johnson & Johnson (J&J)
JNJNYSEUnited States
$615.9B
-2.3% 1W·+32.3% 1Y
- 03
AbbVie Inc.
ABBVNYSEUnited States
$504.4B
+3.2% 1W·+24.3% 1Y
- 04
F. Hoffmann-La Roche AG
ROGSIXSwitzerland
$371.7B
-9.5% 1W·— 1Y
- 05
Merck & Co., Inc.
MRKNYSEUnited States
$360.1B
+0.2% 1W·+72.1% 1Y
- 06
Novartis AG
NOVNSIXSwitzerland
$286.3B
+4.7% 1W·+14.6% 1Y
- 07
Novo Nordisk A/S
NVONYSEDenmark
$170.0B
— 1W·-24.5% 1Y
- 08
Pfizer Inc.
PFENYSEUnited States
$168.6B
+4.6% 1W·— 1Y
- 09
Companhia Bristol-Myers Squibb (BMS)
BMYNYSEUnited States
$122.0B
+1.1% 1W·+37.0% 1Y
- 10
Sanofi S.A.
SNYNYSEFrance
$97.3B
+0.6% 1W·-19.8% 1Y
Exibindo 1–10 de 10